Paul Adepoju

Paul Adepoju pauladepoju

Paul Adepoju is a Nigeria-based Devex Contributing Reporter, academic, and author. He covers health and tech in Africa for leading local and international media outlets including CNN, Quartz, and The Guardian. He's also the founder of healthnews.africa. He is completing a doctorate in cell biology and genetics and holds several reporting awards in health and tech.

Latest Articles

Can Africa’s drug regulators be both fast and trusted?

Can Africa’s drug regulators be both fast and trusted?

3 months ago // Global health

When COVID-19 vaccines arrived, Nigeria’s regulators moved faster than ever. The urgency helped protect lives but also left people with doubts. Now, the experience is helping rebuild trust and prepare for the future.

Can health systems keep pace with HIV prevention’s breakthrough?

Can health systems keep pace with HIV prevention’s breakthrough?

4 months ago // Global health

Lenacapavir trials proved the science works. But experts say the real test is if health systems, governments, and donors can deliver.

Can Africa host its way to inclusion?

Can Africa host its way to inclusion?

5 months ago // Inclusive Development

Hosting global health conferences in Africa may bring the stage closer — but is it breaking down the walls that keep African voices out?

'Malaria thrives on chaos' — and the US aid freeze is creating it

'Malaria thrives on chaos' — and the US aid freeze is creating it

11 months ago // Malaria

Despite waivers for lifesaving programs, the U.S. aid freeze continues to disrupt malaria prevention efforts. The uncertainty and delays threaten to reverse progress, putting millions at risk.

Fatigue and fog: Navigating Nigeria’s long COVID crisis

Fatigue and fog: Navigating Nigeria’s long COVID crisis

12 months ago // Global health

The COVID-19 pandemic may have subsided, but the battle is far from over for millions. In the shadows of recovery lies a new epidemic: long COVID, a silent storm reshaping lives, economies, and health care systems worldwide.

Can saving lives be profitable? These African health startups think so

Can saving lives be profitable? These African health startups think so

about 1 year ago // Global health

Sustainable innovation is crucial for strengthening health systems, particularly in low- and middle-income countries in Africa. But investors have historically been hesitant to engage with Africa's health care sector.

Can personalized medicine alter South Africa's fight against HIV?

Can personalized medicine alter South Africa's fight against HIV?

about 1 year ago // Global Health

South Africa's HIV Host Genome Project seeks to unlock the genetic factors that enable a rare group of HIV-positive individuals, known as "elite controllers," to naturally suppress the virus without needing antiretroviral medication.

How a new vaccine candidate could outpace Lassa fever's deadly grip

How a new vaccine candidate could outpace Lassa fever's deadly grip

over 1 year ago // Global health

The inaugural Phase 2 Lassa fever vaccine clinical trial, supported by CEPI and IAVI, commenced in Nigeria and Liberia.

A new injectable could prevent malaria. What's standing in its way?

A new injectable could prevent malaria. What's standing in its way?

over 1 year ago // Global Health

Though health experts agree that monoclonal antibodies could be the next big thing in malaria prevention, several significant challenges stand in the way of their widespread deployment.

Is brain drain limiting Africa’s genomics potential?

Is brain drain limiting Africa’s genomics potential?

over 1 year ago // Global health

A wide human capacity gap threatens Africa's genomics goals but efforts to train more scientists are being hindered by brain drain as trained scientists migrate abroad in search of better opportunities.